Joseph R. Shaw: Risk Stratification is Only Useful if It is Practical, Consistent, and Easy to Apply at the Bedside
Joseph R. Shaw, Director of Research Program at Ottawa Department of Medicine, EHJ-CVP Associate Editor of European Heart Journal, shared on LinkedIn about a recent article he and his colleagues co-authored, published in JTH, adding:
“Risk stratification is only useful if it is practical, consistent, and easy to apply at the bedside.
In our ISTH SSC guidance document, we propose a revised 3-tier procedural bleed risk framework for anticoagulated patients undergoing planned procedures:
minimal, low/moderate, and high bleed risk.
The goal is to support more consistent perioperative anticoagulation decisions across specialties, while recognizing that the classification is a starting point – not a substitute for clinical judgment.
Patient factors, procedural nuance, local resources, and multidisciplinary input still matter.
I hope this framework helps clinicians, proceduralists, and perioperative teams speak the same language when planning anticoagulant interruption and resumption.
Thanks to Thrombosis Canada and CLOT Conversations for highlighting this work.”
Title: Surgical and procedural bleed risk stratification for anticoagulated patients undergoing planned surgery: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis
Authors: Joseph R. Shaw, Jameel Abdulrehman, Steffan Frosi Stella, Grigorios I. Leontiadis, Jan Steffel, Maria P. Ntalouka, Guillaume Martel, Kari A.O. Tikkinen10, Prism Schneider, Mark Turrentine, Achilleas Thoma, Daniel Lee, Adam P.J.J. Bray, Nick Blanas, Edsel Ing, Risa Shorr, Deborah M. Siegal, Jerrold H. Levy, Jean M. Connors, Alex C. Spyropoulos, James Douketis
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week